PFCS
Pale Fire Capital SE Portfolio holdings
AUM
$958M
1-Year Return
80.1%
This Quarter Return
+7.03%
1 Year Return
+80.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$638M
AUM Growth
-$249M
(-28%)
Cap. Flow
-$250M
Cap. Flow
% of AUM
-39.22%
Top 10 Holdings %
Top 10 Hldgs %
91.27%
Holding
68
New
21
Increased
18
Reduced
13
Closed
10
Top Buys
| 1 |
IAUX
i-80 Gold Corp
IAUX
|
+$11M |
| 2 |
Teladoc Health
TDOC
|
+$9M |
| 3 |
CIM
Chimera Investment
CIM
|
+$5.37M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$3.87M |
| 5 |
Ocular Therapeutix
OCUL
|
+$3.81M |
Top Sells
| 1 |
Shell
SHEL
|
+$143M |
| 2 |
Navios Maritime Partners
NMM
|
+$32.5M |
| 3 |
Dole
DOLE
|
+$26.9M |
| 4 |
Scorpio Tankers
STNG
|
+$22.3M |
| 5 |
AT&T
T
|
+$19.3M |
Sector Composition
| 1 | Communication Services | 51.91% |
| 2 | Consumer Staples | 16.73% |
| 3 | Materials | 12.6% |
| 4 | Energy | 9.01% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
X4 Pharmaceuticals
XFOR
$73.2M
| $1.07M | 0.17% |
53,426
+47,525
| +805% | +$954K |
|
27
RAPT Therapeutics
RAPT
$268M
| $1.03M | 0.16% |
63,841
+61,832
| +3,078% | +$994K |
|
|
MITT
28
AG Mortgage Investment Trust
MITT
$244M
| $1M | 0.16% |
+133,271
| New | +$1M |
|
|
INZY
29
DELISTED
Inozyme Pharma
INZY
| $986K | 0.15% |
188,537
+149,636
| +385% | +$783K |
|
30
ReNew
RNW
$2.76B
| $373K | 0.06% |
59,289
+41,668
| +236% | +$262K |
|
31
Iovance Biotherapeutics
IOVA
$821M
| $351K | 0.06% |
37,375
+22,675
| +154% | +$213K |
|
32
Disc Medicine
IRON
$2.08B
| $325K | 0.05% |
+6,609
| New | +$325K |
|
33
Immatics
IMTX
$707M
| $279K | 0.04% |
24,462
+12,938
| +112% | +$148K |
|
34
Biohaven
BHVN
$1.47B
| $275K | 0.04% |
+5,496
| New | +$275K |
|
35
Celcuity
CELC
$2.33B
| $260K | 0.04% |
17,458
+5,805
| +50% | +$86.6K |
|
|
CMCT
36
Creative Media & Community Trust
CMCT
$6M
| $239K | 0.04% |
1,946
+169
| +10% | +$20.8K |
|
|
CMRX
37
DELISTED
Chimerix, Inc.
CMRX
| $237K | 0.04% |
254,963
+88,756
| +53% | +$82.5K |
|
38
Black Diamond Therapeutics
BDTX
$185M
| $230K | 0.04% |
52,985
+13,985
| +36% | +$60.8K |
|
|
VERV
39
DELISTED
Verve Therapeutics
VERV
| $221K | 0.03% |
+45,600
| New | +$221K |
|
40
TScan Therapeutics
TCRX
$99.9M
| $218K | 0.03% |
43,723
+22,150
| +103% | +$110K |
|
41
Larimar Therapeutics
LRMR
$336M
| $212K | 0.03% |
32,309
+18,017
| +126% | +$118K |
|
42
Edgewise Therapeutics
EWTX
$1.5B
| $205K | 0.03% |
+7,686
| New | +$205K |
|
43
Achieve Life Sciences
ACHV
$157M
| $157K | 0.02% |
+33,119
| New | +$157K |
|
44
Aquestive Therapeutics
AQST
$611M
| $120K | 0.02% |
+24,000
| New | +$120K |
|
45
Rezolute
RZLT
$669M
| $118K | 0.02% |
+24,289
| New | +$118K |
|
|
SYRS
46
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $106K | 0.02% |
+49,211
| New | +$106K |
|
47
Compass Therapeutics
CMPX
$613M
| $56.1K | 0.01% |
30,507
-52,270
| -63% | -$96.2K |
|
48
Cellectar Biosciences
CLRB
$16.2M
| $53.6K | 0.01% |
+834
| New | +$53.6K |
|
|
ODV
49
Osisko Development Corp
ODV
$733M
| $51.7K | 0.01% |
24,291
-10,769
| -31% | -$22.9K |
|
50
Broadwind
BWEN
$51.6M
| $50K | 0.01% |
+22,026
| New | +$50K |
|